Logo image of BON

BON NATURAL LIFE LTD-A (BON) Stock Fundamental Analysis

NASDAQ:BON - Nasdaq - KYG144921130 - Common Stock - Currency: USD

1.02  +0.04 (+3.56%)

After market: 1.05 +0.03 (+2.94%)

Fundamental Rating

6

Overall BON gets a fundamental rating of 6 out of 10. We evaluated BON against 85 industry peers in the Chemicals industry. BON has an excellent profitability rating, but there are some minor concerns on its financial health. BON has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

7

1. Profitability

1.1 Basic Checks

BON had positive earnings in the past year.
In the past year BON has reported a negative cash flow from operations.
In the past 5 years BON has always been profitable.
In multiple years BON reported negative operating cash flow during the last 5 years.
BON Yearly Net Income VS EBIT VS OCF VS FCFBON Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 0 2M -2M 4M -4M 6M

1.2 Ratios

The Return On Assets of BON (4.92%) is better than 72.29% of its industry peers.
Looking at the Return On Equity, with a value of 6.72%, BON is in line with its industry, outperforming 59.04% of the companies in the same industry.
With a decent Return On Invested Capital value of 5.78%, BON is doing good in the industry, outperforming 62.65% of the companies in the same industry.
BON had an Average Return On Invested Capital over the past 3 years of 14.71%. This is significantly above the industry average of 6.82%.
The 3 year average ROIC (14.71%) for BON is well above the current ROIC(5.78%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 4.92%
ROE 6.72%
ROIC 5.78%
ROA(3y)13.07%
ROA(5y)12.88%
ROE(3y)17.23%
ROE(5y)23.63%
ROIC(3y)14.71%
ROIC(5y)17.22%
BON Yearly ROA, ROE, ROICBON Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 10 20 30

1.3 Margins

Looking at the Profit Margin, with a value of 9.65%, BON belongs to the top of the industry, outperforming 83.13% of the companies in the same industry.
In the last couple of years the Profit Margin of BON has grown nicely.
BON's Operating Margin of 11.81% is fine compared to the rest of the industry. BON outperforms 65.06% of its industry peers.
BON's Operating Margin has improved in the last couple of years.
BON's Gross Margin of 27.75% is in line compared to the rest of the industry. BON outperforms 50.60% of its industry peers.
In the last couple of years the Gross Margin of BON has grown nicely.
Industry RankSector Rank
OM 11.81%
PM (TTM) 9.65%
GM 27.75%
OM growth 3Y1.75%
OM growth 5Y29.13%
PM growth 3Y-2.14%
PM growth 5Y49.74%
GM growth 3Y1.6%
GM growth 5Y6.35%
BON Yearly Profit, Operating, Gross MarginsBON Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 10 20 30

More info and screens

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), BON is creating value.
BON has more shares outstanding than it did 1 year ago.
BON has more shares outstanding than it did 5 years ago.
The debt/assets ratio for BON has been reduced compared to a year ago.
BON Yearly Shares OutstandingBON Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 200K 400K 600K 800K 1M
BON Yearly Total Debt VS Total AssetsBON Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M

2.2 Solvency

An Altman-Z score of 1.88 indicates that BON is not a great score, but indicates only limited risk for bankruptcy at the moment.
BON's Altman-Z score of 1.88 is in line compared to the rest of the industry. BON outperforms 51.81% of its industry peers.
BON has a Debt/Equity ratio of 0.16. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.16, BON belongs to the top of the industry, outperforming 80.72% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF N/A
Altman-Z 1.88
ROIC/WACC0.73
WACC7.9%
BON Yearly LT Debt VS Equity VS FCFBON Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 10M 20M 30M

2.3 Liquidity

A Current Ratio of 2.44 indicates that BON has no problem at all paying its short term obligations.
BON's Current ratio of 2.44 is fine compared to the rest of the industry. BON outperforms 65.06% of its industry peers.
BON has a Quick Ratio of 2.32. This indicates that BON is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 2.32, BON belongs to the best of the industry, outperforming 85.54% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.44
Quick Ratio 2.32
BON Yearly Current Assets VS Current LiabilitesBON Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M

More info and screens

6

3. Growth

3.1 Past

The earnings per share for BON have decreased strongly by -61.16% in the last year.
Measured over the past years, BON shows a very strong growth in Earnings Per Share. The EPS has been growing by 77.98% on average per year.
BON shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -15.85%.
BON shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 22.32% yearly.
EPS 1Y (TTM)-61.16%
EPS 3Y9.77%
EPS 5Y77.98%
EPS Q2Q%-100.35%
Revenue 1Y (TTM)-15.85%
Revenue growth 3Y17.45%
Revenue growth 5Y22.32%
Sales Q2Q%-28.03%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
The Revenue is expected to grow by 27.92% on average over the next years. This is a very strong growth
EPS Next Y-89.64%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year26.3%
Revenue Next 2Y49.78%
Revenue Next 3Y38.66%
Revenue Next 5Y27.92%

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
BON Yearly Revenue VS EstimatesBON Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 20M 40M 60M 80M 100M
BON Yearly EPS VS EstimatesBON Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 0.39, the valuation of BON can be described as very cheap.
Based on the Price/Earnings ratio, BON is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
BON is valuated cheaply when we compare the Price/Earnings ratio to 29.75, which is the current average of the S&P500 Index.
BON is valuated cheaply with a Price/Forward Earnings ratio of 1.74.
100.00% of the companies in the same industry are more expensive than BON, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of BON to the average of the S&P500 Index (22.44), we can say BON is valued rather cheaply.
Industry RankSector Rank
PE 0.39
Fwd PE 1.74
BON Price Earnings VS Forward Price EarningsBON Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

BON's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. BON is cheaper than 98.80% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 1.15
BON Per share dataBON EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

The decent profitability rating of BON may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for BON!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BON NATURAL LIFE LTD-A

NASDAQ:BON (3/3/2025, 8:15:31 PM)

After market: 1.05 +0.03 (+2.94%)

1.02

+0.04 (+3.56%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)12-06 2024-12-06
Earnings (Next)N/A N/A
Inst Owners0%
Inst Owner ChangeN/A
Ins Owners48.11%
Ins Owner ChangeN/A
Market Cap4.25M
Analysts0
Price Target79.05 (7650%)
Short Float %1.03%
Short Ratio0.55
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 0.39
Fwd PE 1.74
P/S 0.17
P/FCF N/A
P/OCF N/A
P/B 0.12
P/tB 0.12
EV/EBITDA 1.15
EPS(TTM)2.62
EY256.86%
EPS(NY)0.59
Fwd EY57.43%
FCF(TTM)-0.37
FCFYN/A
OCF(TTM)-0.09
OCFYN/A
SpS6.13
BVpS8.8
TBVpS8.56
PEG (NY)N/A
PEG (5Y)0
Profitability
Industry RankSector Rank
ROA 4.92%
ROE 6.72%
ROCE 7.84%
ROIC 5.78%
ROICexc 5.88%
ROICexgc 6.02%
OM 11.81%
PM (TTM) 9.65%
GM 27.75%
FCFM N/A
ROA(3y)13.07%
ROA(5y)12.88%
ROE(3y)17.23%
ROE(5y)23.63%
ROIC(3y)14.71%
ROIC(5y)17.22%
ROICexc(3y)15.6%
ROICexc(5y)17.89%
ROICexgc(3y)15.87%
ROICexgc(5y)18.14%
ROCE(3y)18.7%
ROCE(5y)23.66%
ROICexcg growth 3Y-12.04%
ROICexcg growth 5Y20.98%
ROICexc growth 3Y-12.52%
ROICexc growth 5Y20.72%
OM growth 3Y1.75%
OM growth 5Y29.13%
PM growth 3Y-2.14%
PM growth 5Y49.74%
GM growth 3Y1.6%
GM growth 5Y6.35%
F-Score3
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF N/A
Debt/EBITDA 1.32
Cap/Depr 86.46%
Cap/Sales 4.59%
Interest Coverage 14.84
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.44
Quick Ratio 2.32
Altman-Z 1.88
F-Score3
WACC7.9%
ROIC/WACC0.73
Cap/Depr(3y)1457.26%
Cap/Depr(5y)1874.6%
Cap/Sales(3y)12.84%
Cap/Sales(5y)21.09%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-61.16%
EPS 3Y9.77%
EPS 5Y77.98%
EPS Q2Q%-100.35%
EPS Next Y-89.64%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-15.85%
Revenue growth 3Y17.45%
Revenue growth 5Y22.32%
Sales Q2Q%-28.03%
Revenue Next Year26.3%
Revenue Next 2Y49.78%
Revenue Next 3Y38.66%
Revenue Next 5Y27.92%
EBIT growth 1Y-55.21%
EBIT growth 3Y19.51%
EBIT growth 5Y57.95%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y76.13%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-118.62%
OCF growth 3YN/A
OCF growth 5YN/A